跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 851 条关于
“[⁶⁸Ga]Ga-PentixaFor”
全部
851
临床试验
473
药物
196
机构
4
资讯
178
11个月前
Pentixapharm's CXCR4-Targeted Radiopharmaceuticals Show Promise in Primary Aldosteronism and Bladder Cancer
去年
AI-Powered OCT Analysis Enhances Understanding of Geographic Atrophy Progression and Treatment Response
去年
Emerging Therapies Offer Hope for Geographic Atrophy Treatment
去年
AAOpt 2024: Early Detection and Treatment of Geographic Atrophy Key to Preserving Vision
9个月前
Pentixapharm Receives FDA Guidance for Phase 3 PANDA Study of 68Ga-PentixaFor in Primary Aldosteronism
去年
Alkeus Pharmaceuticals' Gildeuretinol Shows Promise in Geographic Atrophy Treatment
去年
EU Confirms Rejection of Apellis' Pegcetacoplan for Geographic Atrophy
去年
Alkeus' Oral Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression
去年
NCI and NIDDK Initiate Phase II Trial of PentixaFor for Adrenal Tumor Subtyping
去年
Ga-68 PSMA-11 Tracer Shows Promise in Guiding SCINTIX Therapy for Metastatic Prostate Cancer
第 1 页,共 18 页
上一页
下一页